0001237899-20-000042.txt : 20201006
0001237899-20-000042.hdr.sgml : 20201006
20201006160740
ACCESSION NUMBER: 0001237899-20-000042
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200820
FILED AS OF DATE: 20201006
DATE AS OF CHANGE: 20201006
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McCourt Marion
CENTRAL INDEX KEY: 0001663758
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 201226854
MAIL ADDRESS:
STREET 1: C/O AXOVANT SCIENCES, INC.
STREET 2: 320 WEST 37TH STREET, 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-08-20
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001663758
McCourt Marion
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
SVP Commercial
Common Stock
2020-08-20
4
M
0
1000
342.93
A
14963
D
Common Stock
2020-08-20
4
S
0
1000
612.15
D
13963
D
Common Stock
2020-10-05
4
M
0
1000
342.93
A
14963
D
Common Stock
2020-10-05
4
S
0
1000
600.0
D
13963
D
Common Stock
90
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
342.93
2020-08-20
4
M
0
1000
0.0
D
2028-02-12
Common Stock
1000
19000
D
Non-Qualified Stock Option (right to buy)
342.93
2020-10-05
4
M
0
1000
0.0
D
2028-02-12
Common Stock
1000
18000
D
Represents volume-weighted average price of sales of 1,000 shares of Company stock on August 20, 2020 at prices ranging from $612.13 to $612.25. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 20, 2020 at each separate price.
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Marion McCourt
2020-10-06